[Use of 0.1% dipivefrine chloride for treatment of patients with open angle glaucoma].
OBJECTIVE
Evaluation of eye drops Dipivefrine chloride 0.1% produced by WZF "Polfa".


METHODS
Drug influence on the level of intraocular pressure and outflow facility coefficient was examined, as well as general blood pressure and pulse in patients with open angle glaucoma. Effectiveness of the drug was compared with its analogue produced abroad. The drug was tested in 2 groups of patients, 30 eyes in each. Statistic analysis of examined parametres we done after 2 weeks administration.


RESULTS
Significant decrease of intraocular pressure was found after the administration of 0.1% Dipivefrine Chloride, especially in combined treatment with 0.5% Oftensin. No significant differences were found in outflow facility, and in comparison with the foreign analogue of the drug.
Kliniki Okulistycznej CMKP, Warszawa.
K
K
Czechowicz-Janicka
E
E
Kamińska
J
J
Staszkiewicz
D004359:Drug Therapy, Combination; D004837:Epinephrine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D009883:Ophthalmic Solutions
D009883:Ophthalmic Solutions; C015173:dipivefrin; D004837:Epinephrine
Zastosowanie preparatu 0.1% dipivefrine chloride do leczenia chorych na jaskre z szerokim, otwartym katem przesaczania.